CASE REPORTS

A case of late stage tumor combined with Babesia infection

  • XU Yile ,
  • LI Jiangfeng ,
  • ZHANG Jiaqi ,
  • YU Xianghua ,
  • RUAN Wei
Expand
  • 1 Wenzhou Central Blood Station, Wenzhou 325002, Zhejiang, China
    2 Wenzhou Centre for Disease Control and Prevention, Wenzhou 325002, Zhejiang, China
    3 Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China

Received date: 2023-02-14

  Revised date: 2023-04-26

  Online published: 2023-06-07

Supported by

Zhejiang Province Health Major Science and Technology Program(WKJ-ZJ-2119);Zhejiang Province Basic Public Welfare Research Program(LGF22H260006)

Abstract

A 57-year-old female patient from Lucheng District was admitted to Wenzhou Central Hospital on September 28, 2021. The examination on admission showed the chronic disease face and clear consciousness; the skin and mucous membranes had no yellowish staining nor oedema but were scared. The patient was admitted to the cardiology department with “chest tightness pending further investigation” and was later transferred to the chemotherapy department due to cancerous pleural fluid. The patient had a recurrent fever since October 8. Laboratory tests showed the haemoglobin was 86 g/L, the red blood cell count was 2.74 × 1012/L suggesting moderate anaemia. The leukocyte count was 12.7 × 109/L, the absolute neutrophil count was 10.6 × 109/L. The patient also had mildly elevated total and indirect bilirubin; urine culture detects mixed growth of more than 3 bacteria, persistent urinary occult blood 2 +. Wright’s stain of the blood smear was performed on October 25, microscopic examination showed that 1-4 ringlets with purplish-red nuclei and blue cytoplasmic could be found in some red blood cells, which was considered to be a parasitic infection. The patient was a long-term resident of urban Wenzhou with no history of domestic or international travel, and no clear history of tick bites. The patient underwent breast-conserving surgery for left breast cancer in 2005, received chemotherapy and targeted drug therapy for multiple lung metastases between 2014 and 2021 and had 12 blood transfusions from June to October 2021. The PCR product of blood DNA amplificated by primers specific to Babesia was sequenced and identified with 99.43% homology to B. microti (GenBank accession: MG674832.1). The diagnosis of Babesia microti infection was confirmed. The patient was treated with oral chloroquine phosphate tablets (0.5 g/d, double the first dose for 5 d) and intravenous clindamycin (600 mg/d + saline 500 ml intravenously for 10 d), with some relief of symptoms, and parasites were still detected on microscopic examination after 5 days. The symptoms of high fever, jaundice and haemolysis caused by Babesia infection somewhat exacerbate the progression of terminal-stage cancer. On November 8, the patient died of multi-organ failure and unsuccessful resuscitation.

Cite this article

XU Yile , LI Jiangfeng , ZHANG Jiaqi , YU Xianghua , RUAN Wei . A case of late stage tumor combined with Babesia infection[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023 , 41(3) : 393 -396 . DOI: 10.12140/j.issn.1000-7423.2023.03.021

References

[1] National Health and Wellness Commission of the People’s Republic of China. Blood smear microscopy for the detection of Babesia: WS/T 632—2018[S]. Beijing: People’s Medical Publishing House, 2018: 4-5. (in Chinese)
  (中华人民共和国国家卫生健康委员会. 巴贝虫检测血涂片镜检法: WS/T 632—2018[S]. 北京: 人民卫生出版社, 2018: 4-5.)
[2] National Health and Wellness Commission of the People’s Republic of China. Nucleic acid identification method for the detection of Babesia species: WS/T 633—2018[S]. Beijing: People’s Medical Publishing House, 2018: 6-8. (in Chinese)
  (中华人民共和国国家卫生健康委员会. 巴贝虫检测虫种核酸鉴定法: WS/T 633—2018[S]. 北京: 人民卫生出版社, 2018: 6-8.)
[3] National Health and Family Planning Commission, People’s Republic of China. Diagnosis of babesiosis: WS/T 564—2017[S]. Beijing: People’s Medical Publishing House, 2017: 2. (in Chinese)
  (中华人民共和国国家卫生和计划生育委员会. 巴贝虫病诊断: WS/T 564—2017[S]. 北京: 人民卫生出版社, 2017: 2.)
[4] Yao LN, Ruan W, Zeng CY, et al. Pathogen identification and clinical diagnosis for one case infected with Babesia[J]. Chin J Parasitol Parasit Dis. 2012, 30(2): 118-121. (in Chinese)
  (姚立农, 阮卫, 曾长佑, 等. 1例人感染巴贝虫的诊断与病原体鉴定[J]. 中国寄生虫学与寄生虫病杂志, 2012, 30(2): 118-121.)
[5] Jalovecka M, Sojka D, Ascencio M, et al. Babesia life cycle: when phylogeny meets biology[J]. Trends Parasitol, 2019, 35(5): 356-368.
[6] Chen MX, Xue JB, Ai L, et al. Epidemic status and research progress of babesiosis in China[J]. J Trop Dis Parasitol, 2022, 20(3): 149-157. (in Chinese)
  (陈木新, 薛靖波, 艾琳, 等. 我国巴贝虫病流行现状与研究进展[J]. 热带病与寄生虫学, 2022, 20(3): 149-157.)
[7] Fang DC, Mccullough J. Transfusion-transmitted Babesia microti[J]. Transfus Med Rev, 2016, 30(3): 132-138.
[8] Homer MJ, Aguilar-Delfin I, Telford SR, et al. Babesiosis[J]. Clin Microbiol Rev, 2000, 13(3): 451-69.
[9] Waked R, Krause PJ. Human babesiosis[J]. Infect Dis Clin North Am, 2022, 36(3): 655-670.
[10] Lin H, Ji YH, Chen XL, et al. Sero-prevalence of Babesia infection among voluntary blood donors in Jiangsu Province[J]. Chin J Schisto Control, 2019, 31(5): 516-518, 528. (in Chinese)
  (林红, 姬艺洪, 陈晓莉, 等. 江苏地区无偿献血人群巴贝虫感染调查[J]. 中国血吸虫病防治杂志, 2019, 31(5): 516-518, 528.)
[11] Tang TTM, Tran MH. Transfusion transmitted babesiosis: a systematic review of reported cases[J]. Transfus Apher Sci. 2020, 59(5): 102843.
[12] Bloch EM, Day JR, Krause PJ, et al. Epidemiology of hospitalized patients with babesiosis, United States, 2010—2016[J]. Emerg Infect Dis, 2022, 28(2): 354-362.
[13] Kumar A, O’bryan J, Krause PJ. The global emergence of human babesiosis[J]. Pathogens, 2021, 10(11): 1447.
Outlines

/

〈 〉